Trans‑anal minimally invasive surgery (TAMIS) versus rigid platforms for local excision of early rectal cancer: a systematic review and meta-analysis of the literature.

Early rectal cancer Local excision Meta-analysis Rigid platforms Systematic review Trans‑anal minimally invasive surgery (TAMIS)

Journal

Surgical endoscopy
ISSN: 1432-2218
Titre abrégé: Surg Endosc
Pays: Germany
ID NLM: 8806653

Informations de publication

Date de publication:
18 Jul 2024
Historique:
received: 01 04 2024
accepted: 06 07 2024
medline: 19 7 2024
pubmed: 19 7 2024
entrez: 18 7 2024
Statut: aheadofprint

Résumé

Available platforms for local excision (LE) of early rectal cancer are rigid or flexible [trans‑anal minimally invasive surgery (TAMIS)]. We systematically searched the literature to compare outcomes between platforms. PRISMA-compliant search of PubMed and Scopus databases until September 2022 was undertaken in this random-effect meta-analysis. Statistical heterogeneity was assessed using I 7 studies were published between 2015 and 2022, including 931 patients (423 females); 402 underwent TAMIS and 529 underwent LE with rigid platforms. Techniques were similar for operative time (WMD 11.1, 95%CI - 2.6 to 25, p = 0.11), percentage of defect closure (OR 0.7, 95%CI 0.06-8.22, p = 0.78), and peritoneal violation (OR 0.41, 95%CI 0.12-1.43, p = 0.16). Rigid platforms had higher rates of short-term complications (19.1% vs 14.2, OR 1.6, 95%CI 1.07-2.4, p = 0.02), although no significant differences were seen for major complications (OR 1.41, 95%CI 0.61-3.23, p = 0.41). Patients in the rigid platforms group were 3-times more likely to be re-admitted within 30 days compared to the TAMIS group (OR 3.1, 95%CI 1.07-9.4, p = 0.03). Rates of positive resection margins (rigid platforms: 7.6% vs TAMIS: 9.34%, OR 0.81, 95%CI 0.42-1.55, p = 0.53) and specimen fragmentation (rigid platforms: 3.3% vs TAMIS: 4.4%, OR 0.74, 95%CI 0.33-1.64, p = 0.46) were similar between the groups. Salvage surgery was required in 5.5% of rigid platform patients and 6.2% of TAMIS patients (OR 0.8, 95%CI 0.4-1.8, p = 0.7). TAMIS or rigid platforms for LE seem to have similar operative outcomes and specimen quality. The TAMIS group demonstrated lower readmission and overall complication rates but did not significantly differ for major complications. The choice of platform should be based on availability, cost, and surgeon's preference.

Sections du résumé

BACKGROUND BACKGROUND
Available platforms for local excision (LE) of early rectal cancer are rigid or flexible [trans‑anal minimally invasive surgery (TAMIS)]. We systematically searched the literature to compare outcomes between platforms.
METHODS METHODS
PRISMA-compliant search of PubMed and Scopus databases until September 2022 was undertaken in this random-effect meta-analysis. Statistical heterogeneity was assessed using I
RESULTS RESULTS
7 studies were published between 2015 and 2022, including 931 patients (423 females); 402 underwent TAMIS and 529 underwent LE with rigid platforms. Techniques were similar for operative time (WMD 11.1, 95%CI - 2.6 to 25, p = 0.11), percentage of defect closure (OR 0.7, 95%CI 0.06-8.22, p = 0.78), and peritoneal violation (OR 0.41, 95%CI 0.12-1.43, p = 0.16). Rigid platforms had higher rates of short-term complications (19.1% vs 14.2, OR 1.6, 95%CI 1.07-2.4, p = 0.02), although no significant differences were seen for major complications (OR 1.41, 95%CI 0.61-3.23, p = 0.41). Patients in the rigid platforms group were 3-times more likely to be re-admitted within 30 days compared to the TAMIS group (OR 3.1, 95%CI 1.07-9.4, p = 0.03). Rates of positive resection margins (rigid platforms: 7.6% vs TAMIS: 9.34%, OR 0.81, 95%CI 0.42-1.55, p = 0.53) and specimen fragmentation (rigid platforms: 3.3% vs TAMIS: 4.4%, OR 0.74, 95%CI 0.33-1.64, p = 0.46) were similar between the groups. Salvage surgery was required in 5.5% of rigid platform patients and 6.2% of TAMIS patients (OR 0.8, 95%CI 0.4-1.8, p = 0.7).
CONCLUSION CONCLUSIONS
TAMIS or rigid platforms for LE seem to have similar operative outcomes and specimen quality. The TAMIS group demonstrated lower readmission and overall complication rates but did not significantly differ for major complications. The choice of platform should be based on availability, cost, and surgeon's preference.

Identifiants

pubmed: 39026004
doi: 10.1007/s00464-024-11065-6
pii: 10.1007/s00464-024-11065-6
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s).

Références

https://www.nccn.org/professionals/physician_gls/pdf/rectal.pdf . Accessed 26 June 2023
Glynne-Jones R, Wyrwicz L, Tiret E (2017) Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis treatment and follow-up. Ann Oncol 28:iv22–iv40
doi: 10.1093/annonc/mdx224 pubmed: 28881920
Parks AG, Stuart AE (1973) The management of villous tumours of the large bowel. Br J Surg 60:688–695. https://doi.org/10.1002/bjs.1800600908
doi: 10.1002/bjs.1800600908 pubmed: 4582241
Buess G, Theiss R, Hutterer F et al (1983) Transanal endoscopic surgery of the rectum—testing a new method in animal experiments. Leber Magen Darm 13:73–77
pubmed: 6621245
Atallah S, Albert M, Larach S (2010) Transanal minimally invasive surgery: a giant leap forward. Surg Endosc 24:2200–2205
doi: 10.1007/s00464-010-0927-z pubmed: 20174935
D’Hondt M, Yoshihara E, Dedrye L, Vindevoghel K, Nuytens F, Pottel H (2017) Transanal endoscopic operation for benign rectal lesions and T1 carcinoma. JSLS 21(e2016):00093. https://doi.org/10.4293/JSLS.2016.00093
doi: 10.4293/JSLS.2016.00093
Devane LA, Daly MC, Albert MR (2022) Transanal endoscopic platforms: TAMIS versus rigid platforms: pros and cons. Clin Colon Rectal Surg 35:93–98. https://doi.org/10.1055/s-0041-1742108
doi: 10.1055/s-0041-1742108 pubmed: 35237103 pmcid: 8885160
Page MJ, McKenzie JE, Bossuyt PM, et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https://doi.org/10.1136/bmj.n71
doi: 10.1136/bmj.n71 pubmed: 33782057 pmcid: 8005924
Sterne JA, Hernan MA, Reeves BC, et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919. https://doi.org/10.1136/bmj.i4919
doi: 10.1136/bmj.i4919 pubmed: 27733354 pmcid: 5062054
Clavien PA, Barkun J, de Oliveira ML et al (2009) The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 250:187–196. https://doi.org/10.1097/SLA.0b013e3181b13ca2
doi: 10.1097/SLA.0b013e3181b13ca2 pubmed: 19638912
Melin AA, Kalaskar S, Taylor L, Thompson JS, Ternent C, Langenfeld SJ (2016) Transanal endoscopic microsurgery and transanal minimally invasive surgery: is one technique superior? Am J Surg 212:1063–1067. https://doi.org/10.1016/j.amjsurg.2016.08.017
doi: 10.1016/j.amjsurg.2016.08.017 pubmed: 27810138
Mege D, Bridoux V, Maggiori L, Tuech JJ, Panis Y (2017) What is the best tool for transanal endoscopic microsurgery (TEM)? A case-matched study in 74 patients comparing a standard platform and a disposable material. Int J Colorectal Dis 32:1041–1045. https://doi.org/10.1007/s00384-016-2733-0
doi: 10.1007/s00384-016-2733-0 pubmed: 28011978
Lee L, Edwards K, Hunter IA et al (2017) Quality of local excision for rectal neoplasms using transanal endoscopic microsurgery versus transanal minimally invasive surgery: a multi-institutional matched analysis. Dis Colon Rectum 60:928–935. https://doi.org/10.1097/DCR.0000000000000884
doi: 10.1097/DCR.0000000000000884 pubmed: 28796731
Molina G, Bordeianou L, Shellito P, Sylla P (2016) Transanal endoscopic resection with peritoneal entry: a word of caution. Surg Endosc 30:1816–1825. https://doi.org/10.1007/s00464-015-4452-y
doi: 10.1007/s00464-015-4452-y pubmed: 26264697
Stipa F, Tierno SM, Russo G, Burza A (2022) Trans-anal minimally invasive surgery (TAMIS) versus trans-anal endoscopic microsurgery (TEM): a comparative case-control matched-pairs analysis. Surg Endosc 36:2081–2086. https://doi.org/10.1007/s00464-021-08494-y
doi: 10.1007/s00464-021-08494-y pubmed: 33844090
Van den Eynde F, Jaekers J, Fieuws S, D’Hoore AM, Wolthuis AM (2019) TAMIS is a valuable alternative to TEM for resection of intraluminal rectal tumors. Tech Coloproctol 23:161–166. https://doi.org/10.1007/s10151-019-01954-7
doi: 10.1007/s10151-019-01954-7 pubmed: 30859349
Schwab ME, Hernandez S, Watanaskul S, Chern H, Varma M, Sarin A (2022) Comparison of advanced techniques for local excision of rectal lesions: a case series. BMC Surg 22:117. https://doi.org/10.1186/s12893-022-01543-w
doi: 10.1186/s12893-022-01543-w pubmed: 35346146 pmcid: 8962117
Schünemann H, Brożek J, Guyatt G, Oxman A, eds (2013) GRADE handbook for grading quality of evidence and strength of recommendations. Updated October 2013. The GRADE Working Group
Clancy C, Burke JP, Albert MR, O’Connell PR, Winter DC (2015) Transanal endoscopic microsurgery versus standard transanal excision for the removal of rectal neoplasms: a systematic review and meta-analysis. Dis Colon Rectum 58:254–261. https://doi.org/10.1097/DCR.0000000000000309
doi: 10.1097/DCR.0000000000000309 pubmed: 25585086
Hur H, Bae SU, Han YD et al (2016) Transanal endoscopic operation for rectal tumor: short-term outcomes and learning curve analysis. Surg Laparosc Endosc Percutan Tech 26:236–243. https://doi.org/10.1097/SLE.0000000000000258
doi: 10.1097/SLE.0000000000000258 pubmed: 27077220
Lee L, Kelly J, Nassif GJ et al (2018) Establishing the learning curve of transanal minimally invasive surgery for local excision of rectal neoplasms. Surg Endosc 32:1368–1376. https://doi.org/10.1007/s00464-017-5817-1
doi: 10.1007/s00464-017-5817-1 pubmed: 28812153
Maya A, Vorenberg A, Oviedo M, da Silva G, Wexner SD, Sands D (2014) Learning curve for transanal endoscopic microsurgery: a single-center experience. Surg Endosc 28:1407–1412. https://doi.org/10.1007/s00464-013-3341-5
doi: 10.1007/s00464-013-3341-5 pubmed: 24366188
Barendse RM, Dijkgraaf MG, Rolf UR et al (2013) Colorectal surgeons’ learning curve of transanal endoscopic microsurgery. Surg Endosc 27:3591–3602. https://doi.org/10.1007/s00464-013-2931-6
doi: 10.1007/s00464-013-2931-6 pubmed: 23572216
Serra-Aracil X, Badia-Closa J, Pallisera-Lloveras A et al (2021) Management of intra- and postoperative complications during TEM/TAMIS procedures: a systematic review. Minerva Surg 76:343–349. https://doi.org/10.23736/S2724-5691.20.08405-9
doi: 10.23736/S2724-5691.20.08405-9 pubmed: 33433070
Marinello FG, Curell A, Tapiolas I, Pellino G, Vallribera F, Espin E (2020) Systematic review of functional outcomes and quality of life after transanal endoscopic microsurgery and transanal minimally invasive surgery: a word of caution. Int J Colorectal Dis 35:51–67. https://doi.org/10.1007/s00384-019-03439-3
doi: 10.1007/s00384-019-03439-3 pubmed: 31761962
Goldenshluger M, Gutman Y, Katz A (2020) Long-term bowel function after transanal minimally invasive surgery (TAMIS). Isr Med Assoc J 22:426–430
pubmed: 33236567
Yu JX, Russell WA, Ching JH, Kim N, Bendavid E, Owens DK, Kaltenbach T (2019) Cost effectiveness of endoscopic resection vs transanal resection of complex benign rectal polyps. Clin Gastroenterol Hepatol 17(13):2740–2748.e6. https://doi.org/10.1016/j.cgh.2019.02.041
doi: 10.1016/j.cgh.2019.02.041 pubmed: 30849517

Auteurs

Zoe Garoufalia (Z)

Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL, 33331, USA.

Peter Rogers (P)

Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL, 33331, USA.

Sarinya Meknarit (S)

FAU Charles E. Schmidt College of Medicine, Boca Raton, FL, USA.

Sofoklis Mavrantonis (S)

Bart's and the London School of Medicine and Dentistry, London, UK.

Pauline Aeschbacher (P)

Department of General Surgery and Bariatric and Metabolic Institute, Cleveland Clinic Florida, Weston, FL, USA.
Department for Visceral Surgery and Medicine, Bern University Hospital, University of Bern, Bern, Switzerland.

Emeka Ray-Offor (E)

Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL, 33331, USA.
Department of Surgery, University of Port Harcourt Teaching Hospital, Port Harcourt, Nigeria.

Sameh Hany Emile (SH)

Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL, 33331, USA.
Colorectal Surgery Unit, General Surgery Department, Mansoura University Hospitals, Mansoura, Egypt.

Rachel Gefen (R)

Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL, 33331, USA.
Department of General Surgery, Hadassah Medical Organization and Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel.

Justin Dourado (J)

Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL, 33331, USA.

Nir Horesh (N)

Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL, 33331, USA.
Department of Surgery and Transplantations, Sheba Medical Center, Ramat Gan, Israel.

Steven D Wexner (SD)

Ellen Leifer Shulman and Steven Shulman Digestive Disease Center, Cleveland Clinic Florida, 2950 Cleveland Clinic Blvd, Weston, FL, 33331, USA. wexners@ccf.org.

Classifications MeSH